Page last updated: 2024-08-24

capecitabine and Laryngeal Neoplasms

capecitabine has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, D; Kim, JC; Kim, JH; Lee, JE; Park, SH; Sohn, JH	1

Other Studies

1 other study(ies) available for capecitabine and Laryngeal Neoplasms

Article	Year
Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma. Ear, nose, & throat journal, 2016, Volume: 95, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome	2016

Article

Year

Concurrent chemoradiotherapy with capecitabine/cisplatin versus 5-fluorouracil/cisplatin in resectable laryngohypopharyngeal squamous cell carcinoma.

Ear, nose, & throat journal, 2016, Volume: 95, Issue:2

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome

2016